MODERNA’S EXPERIMENTAL COVID-19 VACCINE SHOWS PROMISE IN EARLY-STAGE STUDY

Coronavirus (COVID-19) News Desk

Mon 18 May 2020:

Moderna Inc said on Monday its experimental vaccine for COVID-19 showed promise in early trials and it looks to advance the vaccine into late-stage trials in July.

The vaccine, mRNA-1273, was also found to be generally safe and well tolerated in the early-stage study, the drug developer said.

Think your friends would be interested? Share this story!

Leave a Reply

Your email address will not be published. Required fields are marked *